Elevation Oncology shares rise on new coverage by JPM, target upbeat By Investing.com
[ad_1] © Reuters. Thursday – Elevation Oncology (NASDAQ:ELEV) has received a new Market Outperform rating from JMP Securities, accompanied by an optimistic price target of...
CG Oncology stock initiated with buy rating and $75 target by H.C. Wainwright By Investing.com
[ad_1] © Reuters. On Wednesday, H.C. Wainwright initiated coverage on CG Oncology (NASDAQ:CGON), issuing a Buy rating and setting a price target of $75.00. The...